Outcome-based contract for continuous, uninterrupted reagent supplies for the Abbott i-STAT analyzer at Pine Ridge Indian Hospital Laboratory. Key performance outcomes include continuous supply availability, product usability, regulatory compliance, and cold chain integrity. Performance metrics include stockout incidents, on-time delivery, product acceptance rate, shelf-life compliance, and cold chain temperature excursions. Remedies for non-performance include mandatory replacement, rejection of shipments, and potential termination. The contract is a 100% Indian Small Business Economic Enterprise (ISBEE) set-aside. Award will be made to the lowest priced technically acceptable offeror. Quotes are due August 13, 2026, 12:00 PM MST.
The period of performance is 1 year from the date of award.
Payment is contingent upon meeting performance outcomes. Invoices shall reflect only accepted deliveries and be submitted via IPP, including supporting documentation.
The solicitation requests terms of any express warranty.
Award will be made to the responsible offeror submitting the lowest evaluated price that is determined to be technically acceptable.
Offerors must demonstrate the ability to procure and supply genuine Abbott i-STAT products through authorized channels, maintain uninterrupted supply, meet cold chain and delivery requirements, and provide compliant and usable products.
Failure to meet performance standards will result in mandatory replacement of noncompliant items, rejection of shipments, performance documentation impacting CPARS, increased surveillance, and potential termination for cause.
Failure to provide sufficient documentation demonstrating the ability to obtain and supply authentic Abbott i-STAT products may result in the quotation being determined technically unacceptable.
The total cost of the contract, including option years, is $32,****.